New mutation-testing technology has potential to guide targeted lung and colorectal cancer therapies

(Elsevier Health Sciences) A new technology suitable for practical clinical testing can detect KRAS gene mutations in lung and colorectal cancers and could thereby facilitate targeted therapies, according to a new report in The Journal of Molecular Diagnostics.